Home › Targets › D3

D3 (2 companies · 9 programs)

Companies with an active program directed at D3.

REVIVA PHARMACEUTICALS HOLDINGS, INC. RVPH

brilaroxazine — Schizophrenia Phase 3
brilaroxazine — Bipolar Disorder
brilaroxazine — Major Depressive Disorder
brilaroxazine — Attention-Deficit/Hyperactivity Disorder
brilaroxazine — Behavioral and Psychotic Symptoms of Dementia
brilaroxazine — Parkinson's Disease Psychosis

LB Pharmaceuticals Inc. LBRX

LB-102 — Schizophrenia Phase 3
LB-102 — Bipolar Depression Phase 2
LB-102 — Major Depressive Disorder Phase 1